Literature DB >> 28786026

Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Kathleen E Sullivan1, Hamid Bassiri2, Ahmed A Bousfiha3, Beatriz T Costa-Carvalho4, Alexandra F Freeman5, David Hagin6, Yu L Lau7,8, Michail S Lionakis9, Ileana Moreira10, Jorge A Pinto11, M Isabel de Moraes-Pinto12, Amit Rawat13, Shereen M Reda14, Saul Oswaldo Lugo Reyes15, Mikko Seppänen16, Mimi L K Tang17.   

Abstract

In today's global economy and affordable vacation travel, it is increasingly important that visitors to another country and their physician be familiar with emerging infections, infections unique to a specific geographic region, and risks related to the process of travel. This is never more important than for patients with primary immunodeficiency disorders (PIDD). A recent review addressing common causes of fever in travelers provides important information for the general population Thwaites and Day (N Engl J Med 376:548-560, 2017). This review covers critical infectious and management concerns specifically related to travel for patients with PIDD. This review will discuss the context of the changing landscape of infections, highlight specific infections of concern, and profile distinct infection phenotypes in patients who are immune compromised. The organization of this review will address the environment driving emerging infections and several concerns unique to patients with PIDD. The first section addresses general considerations, the second section profiles specific infections organized according to mechanism of transmission, and the third section focuses on unique phenotypes and unique susceptibilities in patients with PIDDs. This review does not address most parasitic diseases. Reference tables provide easily accessible information on a broader range of infections than is described in the text.

Entities:  

Keywords:  Emerging infections; Global warming; IVIG; PIDD; Phenotypes; Resistance

Mesh:

Year:  2017        PMID: 28786026      PMCID: PMC5693703          DOI: 10.1007/s10875-017-0426-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  355 in total

1.  Merkel cell polyomavirus in Merkel cell carcinoma from a Brazilian epidermodysplasia verruciformis patient.

Authors:  Walmar R Oliveira; Mirian N Sotto; Cyro Festa; Peter Rady; Stephen K Tyring
Journal:  J Am Acad Dermatol       Date:  2010-05       Impact factor: 11.527

2.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XII. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PREVENTION AND ATTENUATION OF MEASLES.

Authors:  C W Ordman; C G Jennings; C A Janeway
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

3.  Hemophagocytic lymphohistiocytosis with isolated central nervous system reactivation and optic nerve involvement.

Authors:  Kok Wee Chong; Jan Hau Lee; Chew Thye Choong; M Med Paeds; Derrick Wei Shih Chan; Marielle V Fortier; Mei Yoke Chan
Journal:  J Child Neurol       Date:  2012-02-28       Impact factor: 1.987

4.  Chikungunya disease.

Authors:  J J Deller; P K Russell
Journal:  Am J Trop Med Hyg       Date:  1968-01       Impact factor: 2.345

5.  Treatment of Chronic Enterovirus Encephalitis With Fluoxetine in a Patient With X-Linked Agammaglobulinemia.

Authors:  Jacqueline Gofshteyn; Ana María Cárdenas; David Bearden
Journal:  Pediatr Neurol       Date:  2016-06-25       Impact factor: 3.372

6.  Merkel cell polyomavirus detection in a patient with familial epidermodysplasia verruciformis.

Authors:  Eun-Kyung M Kwon; Christian R Halvorson; Peter Rady; Stephen Tyring; Harrison P Nguyen; Grace F Kao; Anthony A Gaspari
Journal:  Pediatr Dermatol       Date:  2013-03-28       Impact factor: 1.588

7.  Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation.

Authors:  P le Coutre; H Meisel; J Hofmann; C Röcken; G L Vuong; S Neuburger; P G Hemmati; B Dörken; R Arnold
Journal:  Gut       Date:  2009-05       Impact factor: 23.059

8.  Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital.

Authors:  Kazuo Satoh; Koichi Makimura; Yayoi Hasumi; Yayoi Nishiyama; Katsuhisa Uchida; Hideyo Yamaguchi
Journal:  Microbiol Immunol       Date:  2009-01       Impact factor: 1.955

9.  Laboratory-acquired buffalopox virus infection, India.

Authors:  Thachamvally Riyesh; Shanmugasundaram Karuppusamy; Bidhan C Bera; Sanjay Barua; Nitin Virmani; Sarita Yadav; Rajesh K Vaid; Taruna Anand; Manish Bansal; Praveen Malik; Inderjeet Pahuja; Raj K Singh
Journal:  Emerg Infect Dis       Date:  2014-02       Impact factor: 6.883

10.  The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide.

Authors:  Carlos A Guerra; Priscilla W Gikandi; Andrew J Tatem; Abdisalan M Noor; Dave L Smith; Simon I Hay; Robert W Snow
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069

View more
  2 in total

1.  Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment.

Authors:  Beatriz T Costa-Carvalho; Kathleen E Sullivan; Patrícia M Fontes; Fernanda Aimé-Nobre; Isabela G S Gonzales; Elaine S Lima; Celso Granato; Maria Isabel de Moraes-Pinto
Journal:  J Clin Immunol       Date:  2018-07-14       Impact factor: 8.317

2.  A history of over 40 years of potentially pathogenic free-living amoeba studies in Brazil - a systematic review.

Authors:  Natália Karla Bellini; Otavio Henrique Thiemann; María Reyes-Batlle; Jacob Lorenzo-Morales; Adriana Oliveira Costa
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-07-01       Impact factor: 2.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.